Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

1. National Clinical Guideline on nutrition screening and oral nutrition support for adults

National Clinical Guideline on nutrition screening and oral nutrition support for adults Gov.ie - Nutrition screening and use of oral nutrition support for adults in the acute care setting A notice about cookies This website uses cookies. Some cookies may have been set already. To find out more about our use of cookies you can visit our Privacy policy. By browsing this website, you agree to our use of cookies. BETA This is a prototype - your will help us to improve it. Collection Nutrition (...) screening and use of oral nutrition support for adults in the acute care setting Published: 20 April 2020 From: Nutrition screening and use of oral nutrition support for adults in the acute care setting Guideline Number: 22 Publication Date: April 2020 Nutrition screening and use of oral nutrition support for adults in the acute care setting - National Clinical Guidleline No. 22 Full Report Nutrition screening and use of oral nutrition support for adults in the acute care setting - National Clinical

2020 HIQA Guidelines

2. Rapid Review: Diabetic retinopathy screening during the COVID-19 pandemic

Rapid Review: Diabetic retinopathy screening during the COVID-19 pandemic Rapid Review: Diabetic retinopathy screening during the COVID-19 pandemic - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Rapid Review: Diabetic retinopathy screening during the COVID-19 pandemic May 12, 2020 Ehtasham Ahmad, Melanie J Davies, Kamlesh Khunti BACKGROUND People with diabetes (PWD) are included in the group (...) at increased risk of severe illness from coronavirus (COVID-19) and have been advised to observe stringent social distancing measures.(1) This creates a difficult situation for PWD and their Health Care Providers (HCP) as PWD require an annual review including retinal screening as part of their screening for complications, which involves a physical visit to a community or hospital facility or an eye clinic. This rapid review addresses the following questions: How can we help stratify annual retinal

2020 Oxford COVID-19 Evidence Service

3. Breast screening: GE Healthcare Senographe Pristina DBT System

Breast screening: GE Healthcare Senographe Pristina DBT System Breast screening: GE Healthcare Senographe Pristina DBT System - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Coronavirus guidance is being updated. Read Stay alert. Control the virus. Save lives. Guidance Breast screening (...) : GE Healthcare Senographe Pristina DBT System Practical evaluation of GE Healthcare Senographe Pristina digital breast tomosynthesis system used in the NHS breast screening programme. Published 21 April 2020 From: Documents Ref: PHE publications gateway number: GW-1125 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you

2020 Public Health England

4. Position Statement on COVID-19 and Acute Heart Failure: screening the critically ill

Position Statement on COVID-19 and Acute Heart Failure: screening the critically ill 1 COVID-19 and acute heart failure: screening the critically ill Sean Lal 1* , Christopher Hayward 2* , Carmine De Pasquale 3 , David Kaye 4 , George Javorsky 5 , Peter Bergin 4 , John Atherton 12 , Marcus Ilton 6 , Robert Weintraub 7 , Priya Nair 2 , Mate Rudas 1 , Lawrence Dembo 10 , Robert Doughty 11 , Gayathri Kumarasinghe 13 , Craig Juergens 13 , Paul Bannon 1 , Nicole Bart 2 , Clara Chow 8 , Jo-Dee (...) /4/20 2 There is a need to screen for acute heart failure in critically ill COVID-19 patients. Up to one- third of COVID-19 patients who are admitted to the ICU, albeit a select population, develop an acute cardiomyopathy [1], which could represent myocarditis or stress cardiomyopathy. Fulminant myocarditis has been identified as a cause of death in younger patients with Middle East Respiratory Syndrome [2], and a similar trend may follow with COVID-19, even though younger age groups comprise

2020 Cardiac Society of Australia and New Zealand

5. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic CHEST Expert Panel Report Q21 Peter J. Mazzone, MD, MPH, FCCP; Michael K. Gould, MD, FCCP; Douglas A. Arenberg, MD, FCCP; Alexander C. Chen, MD; Humberto K. Choi, MD, FCCP; Frank C. Detterbeck, MD, FCCP; Farhood Farjah, MD, MPH; Kwun M. Fong, MD; Jonathan M. Iaccarino, MD; Samuel M. Janes, PhD; Jeffrey P (...) thathasoccurredtocombatthe pandemic,havealtered thebalance of bene?ts and harms that informed current (pre-COVID-19) guideline recommendations for lung cancer screening and lung nodule evaluation. RESEARCHQUESTION: Q6 Consensus statements were developed to guide clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. STUDYDESIGNANDMETHODS:Anexpert panelof24members,includingpulmonologists(n¼ 17), thoracic radiologists (n¼ 5), and thoracic surgeons (n¼ 2), was formed

2020 American College of Chest Physicians

6. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial

Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) JAMA Intern Med Actions . 2020 Apr 20;e200440. doi: 10.1001/jamainternmed.2020.0440. Online ahead of print. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Division of General Medicine, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 2 Division of Geriatric Medicine, Department of Medicine, The University

2020 EvidenceUpdates

7. Geriatric Screening, Triage Urgency, and 30-Day Mortality in Older Emergency Department Patients Full Text available with Trip Pro

Geriatric Screening, Triage Urgency, and 30-Day Mortality in Older Emergency Department Patients Geriatric Screening, Triage Urgency, and 30-Day Mortality in Older Emergency Department Patients - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center (...) . 2020 Apr 4. doi: 10.1111/jgs.16427. Online ahead of print. Geriatric Screening, Triage Urgency, and 30-Day Mortality in Older Emergency Department Patients , , , , , , , , , Affiliations Expand Affiliations 1 Department of Internal Medicine, Section Geriatrics, Leiden University Medical Center, Leiden, The Netherlands. 2 Department of Emergency Medicine, Leiden University Medical Center, Leiden, The Netherlands. 3 Department of Emergency Medicine, Spaarne Gasthuis, Haarlem, The Netherlands. 4

2020 EvidenceUpdates

8. AIM Clinical Appropriateness Guidelines for Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis

AIM Clinical Appropriateness Guidelines for Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis Appropriate.Safe.Affordable © 2019 AIM Specialty Health 2068-0319 Clinical Appropriateness Guidelines Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis EFFECTIVE MARCH 3, 2020 PROPRIETARY Guidelines developed by, and used with permission from, Informed Medical Decisions, Inc. © 2019 Informed Medical Decisions, Inc. All Rights Reserved. 2 Table of Contents (...) Scope 3 Appropriate Use Criteria 3 Carrier Screening for Familial Disease 3 Fragile X 3 Carrier Screening for Common and Ethnic Genetic Diseases 3 Cystic Fibrosis 3 Spinal Muscular Atrophy 4 Hemoglobinopathies 4 Ashkenazi Jewish Carrier Screening 4 Other Ethnicities 5 Carrier Screening Not Clinically Appropriate 5 Preimplantation Genetic Screening and Diagnostic Testing of Embryos 5 Preimplantation Genetic Screening for Common Aneuploidy 6 Prenatal Cell-Free DNA Screening 6 Prenatal Molecular

2020 AIM Specialty Health

9. COVID-19 Clinical Screening Assessment Tool

COVID-19 Clinical Screening Assessment Tool COVID-19 CLINICAL SCREENING ASSESSMENT DO NOT WRITE IN THIS BINDING MARGIN Page 1 of 1 label here) URN: Family name: Given name(s): Address: Date of birth: Sex: M F I COVID-19 Clinical Screening Assessment Facility: v3.00 - 04/2020 Do not reproduce by photocopying SW998 2020 Name: Designation: Signature: Date: 1. Reason for Presentation: 2. Recent international travel history No Yes (in the 14 days prior to illness onset) 3. Location of recent travel (...) : Temperature: 11. Additional Information: 12. Outcome Advice only - no testing required based on guidelines at time of screening assessment Instructed to self-quarantine and present for testing if becomes symptomatic Tested - follow up required (patient instructed to self-isolate) Refer for Direct Admission Refer to Emergency Department Refer to GP Refer to QH Clinic Other: For further information on current guidelines visit Australian Government: The Department of Health website: https://www1

2020 Queensland Health

10. Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening

Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Pregnant persons not at increased risk for preterm delivery The USPSTF recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery. D Pregnant persons at increased risk for preterm delivery The USPSTF concludes (...) that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery. I View the Clinical Summary in What does the USPSTF recommend? For pregnant persons not at increased risk for preterm delivery: Grade D Do not screen for bacterial vaginosis in pregnant persons who have no signs or symptoms of bacterial vaginosis. For pregnant persons at increased risk for preterm delivery: I statement The evidence

2020 U.S. Preventive Services Task Force

11. Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum

Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum Translating evidence into best clinical practice Queensland Health NOTICE OF UPDATE DURING COVID-19 PANDEMIC DATE 14 April 2020 TOPIC Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum APPLIES TO All pregnant and postnatal women irrespective of COVID-19 status RATIONALE During the COVID-19 pandemic • Supports social distancing (...) . there is no requirement to alter request for OGTT if this has already been recommended to the woman) SECTION OF GUIDELINE AFFECTED BY UPDATE • Flowchart: Screening and diagnosis of GDM (updated flow available) • Section 2.5 Testing for GDM (updated) • Section 6.3 Discharge planning (updated) UPDATED RECOMMENDATION All women (irrespective of COVID-19 status) • If clinical features of concern emerge during pregnancy (e.g. macrosomia, fetus accelerating through centiles, other concerns), then recommend usual screening

2020 Queensland Health

12. ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests

ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests COVID-19 - ASCCP ');//]]> Register Today! Virtual Conference Starting Soon. Colposcopy Standards Recommendations Recommendations on New Standards of Colposcopy Practice Webinars Live and On-Demand Member Resources ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests March 19, 2020 - In light (...) of the current unprecedented COVID-19 pandemic, and in settings where all non-essential medical office visits and elective procedures have been suspended, ASCCP recommends the following: Individuals with low-grade cervical cancer screening tests may have postponement of diagnostic evaluations up to 6-12 months. Individuals with high-grade cervical cancer screening tests should have documented attempts to contact and diagnostic evaluation scheduled within 3 months. Individuals with high-grade cervical disease

2020 American Society for Clinical Pathology

13. Screening for Hepatitis C Virus Infection

Screening for Hepatitis C Virus Infection Screening for Hepatitis C Virus Infection | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Screening for Hepatitis C Virus Infection Practice Advisory April 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The on March 2, 2020. New guidance from both the CDC and the USPSTF represent a change in routine screening (...) for HCV; both organizations now recommend HCV screening for all adults, including pregnant and nonpregnant individuals. The American College of Obstetricians and Gynecologists (ACOG) is actively reviewing the new guidance from the CDC and USPSTF. Updated guidance from ACOG will be posted on ACOG’s website and published in Obstetrics & Gynecology when available. ACOG is also reviewing its current guidance on the screening and management of hepatitis for pregnant individuals in ACOG Practice Bulletin

2020 American College of Obstetricians and Gynecologists

14. Legal Considerations in Genetic Screening and Testing: Three Case Studies

Legal Considerations in Genetic Screening and Testing: Three Case Studies Legal Considerations in Genetic Screening and Testing: Three Case Studies | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Legal Considerations in Genetic Screening and Testing: Three Case Studies Committee Opinion Number 805 April 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions (...) and Gynecologists’ documents, including Committee Opinion No. 777 Sexual Assault and Committee Opinion No. 518 Intimate Partner Violence for further resources. Adequate pretest counseling and screening, including an extensive family history, may help to avoid discovering information unexpectedly. Patients should be made aware that information about blood relatedness may be revealed by some prenatal genetic tests. Because of the complex genetic, ethical, and legal implications of discovering such information

2020 American College of Obstetricians and Gynecologists

15. Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department

Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library (...) navigation J Pediatr Actions . 2020 Apr;219:54-61.e1. doi: 10.1016/j.jpeds.2019.12.046. Epub 2020 Feb 24. Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department , , , , , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: qdoan@bcchr.ca. 2 Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. 3 Faculty of Medicine, University of British Columbia

2020 EvidenceUpdates

16. Screening strategies to identify sepsis in the prehospital setting: a validation study Full Text available with Trip Pro

Screening strategies to identify sepsis in the prehospital setting: a validation study Screening Strategies to Identify Sepsis in the Prehospital Setting: A Validation Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library (...) navigation CMAJ Actions . 2020 Mar 9;192(10):E230-E239. doi: 10.1503/cmaj.190966. Screening Strategies to Identify Sepsis in the Prehospital Setting: A Validation Study , , , , , , Affiliations Expand Affiliations 1 Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health (Lane, Wunsch, Saskin, Lin, Scales), Interdepartmental Division of Critical Care (Wunsch, Scales), Division of Emergency Medicine, Department of Family and Community Medicine (Cheskes), and Division

2020 EvidenceUpdates

17. Cervical screening: ideas for improving access and uptake

Cervical screening: ideas for improving access and uptake Cervical screening: ideas for improving access and uptake - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Cervical screening: ideas for improving access and uptake Guidance to help primary care, commissioners and local (...) authorities plan and evaluate initiatives around cervical screening coverage in their area. Published 3 March 2020 From: Contents The following initiatives can be used to address areas of low coverage identified in the cervical screening quarterly coverage data reports. Invitation letter Evidence demonstrates that GP endorsement has a positive effect on cervical screening uptake. The cervical screening programme sends a standard invitation letter and a reminder letter 18 weeks later to women who

2020 Public Health England

18. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europ

Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europ Position Statement Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Societyof Gastrointestinal Endoscopy (ESGE) Position Statement Authors AdrianSaftoiu 1,2 ,CesareHassan 3 ,MiguelAreia 4,5 ,ManoopS. Bhutani 6 ,RafBisschops 7 ,ErwanBories 8 ,IrinaM. Cazacu 1,6 ,EvelienDekker 9 , PierreH.Deprez 10 ,StephenP.Pereira 11 ,CarloSenore 12 ,RiccardoCapocaccia 13 (...) 10 Departmentof Hepato-Gastroenterology,Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium 11 Institutefor Liver and Digestive Health, Royal Free Hospital Campus, University College London, UK 12 Epidemiology and Screening Unit-CPO, University Hospital Città della Salute e della Scienza, Turin, Italy 13 Editorial Board, Epidemiologia e Prevenzione 14 III Med Klinik, Klinikum Augsburg, Augsburg, Germany 15 Departmentof Gastroenterology and Hepatology, Radboud

2020 European Society of Gastrointestinal Endoscopy

19. Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee

Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee ClinicalKey

2020 CPG Infobase

20. Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer

Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer canceraustralia.gov.au Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer This resource is for all members of the multidisciplinary shared care team. It provides guidance on the screening, assessment and management of supportive care needs of women affected by low-risk (...) . Screening, assessing and managing the effects of treatment, co-morbidities and secondary prevention are important aspects of a holistic and multidisciplinary approach to managing follow-up care for women with low-risk endometrial cancer. Referral to appropriate health providers is required to meet the identified needs of the woman, her carer and family. SHARED FOLLOW-UP AND SURVIVORSHIP CARE FOR LOW-RISK ENDOMETRIAL CANCER * Evidence suggests that cardiovascular disease is the leading cause of death

2020 Cancer Australia